Randy Brenner
Consejero General en PARATEK PHARMACEUTICALS, INC. .
Perfil
Randy Brenner is currently the Chief Development & Regulatory Officer at Paratek Pharmaceuticals, Inc. He previously worked at Pfizer Inc. as the Vice President-Established Products Business Units from 2010 to 2011.
He also worked at Shire Plc as the Head-Regulatory Affairs.
Mr. Brenner completed his undergraduate degree at Muhlenberg College and his graduate degree at Temple University School of Pharmacy.
Cargos activos de Randy Brenner
Empresas | Cargo | Inicio |
---|---|---|
PARATEK PHARMACEUTICALS, INC. | Consejero General | 03/06/2015 |
Antiguos cargos conocidos de Randy Brenner.
Empresas | Cargo | Fin |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01/09/2011 |
SHIRE | Corporate Officer/Principal | - |
Formación de Randy Brenner.
Muhlenberg College | Undergraduate Degree |
Temple University School of Pharmacy | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PARATEK PHARMACEUTICALS, INC. | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Randy Brenner